Exclaim Study Steering Committee
NEW YORK, July 6, 2010 - The Steering Committee of the EXCLAIM study that explored the
benefit of extended prophylaxis of venous thrombo embolism (VTE) with
enoxaparin in acutely ill medical patients, announced today the publication
of the comprehensive study results in the peer-reviewed journal Annals of
Internal Medicine.
